Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditor’s report)
Click to download
Pipeline Supplemental
Click to download
Earnings Release Presentation
For Media
A Competitive, Values-based, R&D-driven, Global Biopharmaceutical Leader
Christophe Weber, President & Chief Executive Officer, and others
Click to download
For Investors and Analysts
A Competitive, Values-based, R&D-driven, Global Biopharmaceutical Leader
Christophe Weber, President & Chief Executive Officer
Andrew Plump, President, Research & Development
Costa Saroukos, Chief Financial Officer, and others
Click to download
Supplementary materials for the financial statements: Underlying Core & Adjusted EBITDA Reconciliation
Click to download
Quarterly Securities Report (FY2018 Q3)
Click to download
Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditor's Report)
Click to download
Data Book
Click to download
Earnings Release Presentation
1.Strategic Focus & Superior Execution FY2018 Q3 Results
Costa Saroukos, Chief Financial Officer
Click to download
2.Supplementary materials for the financial statements: Underlying Core & Adjusted EBITDA Reconciliation
Presentation
J.P. Morgan Healthcare Conference Presentation
Click to download
Audio
・Conference call
・Q&A
*Link to J.P.Morgan website
Presentation
A Global, Values-based, R&D-driven Biopharmaceutical Leader
Click to download
Click here to see the video (for IR)
Consolidated Statement of Cash Flows
Click to download
Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditor's Report)
Click to download
Data Book
Click to download
Earnings Release Presentation
For Media:
Strategic Focus & Superior Execution FY2018 Q2 Results
Christophe Weber, President & Chief Executive Officer
Click to download
For Investors & Analysts:
Strategic Focus & Superior Execution FY2018 Q2 Results
Christophe Weber, President & Chief Executive Officer
Andrew Plump, Chief Medical & Scientific Officer
Costa Saroukos, Chief Financial Officer
Click to download
Creating a Values based, R&D driven Global Biopharmaceutical Leader
Christophe Weber, President & Chief Executive Officer
Click to download
Supplementary materials for the financial statements: Underlying Core Reconciliation
Click to download
Click here to listen to the Audio
Presentation
DELIVERING ON OUR R&D VISION
Andy Plump, Chief Medical and Scientific Officer
Click to download
Video
*Link to Digital Media Solutions’ website
Presentation
DELIVERING ON OUR R&D VISION
Andy Plump, Chief Medical and Scientific Officer
Click to download
Video
*Link to Nomura IR's website
Consolidated Financial Statements submitted to TSE(Tokyo Stock Exchange)
(Without Independent Auditor's report)
Click to download
Data Book
Partial correction of Data Book(September 11th,2018)
Click to download(After correction)
Earnings Release Conference Call
1. Consolidated Financial Results for FY2018 Q1
Costa Saroukos, Chief Financial Officer
Click to download
2. Supplemantary materials for the financial statements: Underlying Core Reconciliation
Click to download
Click here to listen to the Audio
Presentation
Takeda to Acquire Shire-Accelerating Takeda’s Transformation to Deliver More for Patients
Presentation website for Investors (from 4:15pm)
Click here to listen to the audio for May 8th (for Media & IR)
Click here to listen to the audio for May 9th (for Media & IR)